Processed foods may harm the good bacteria in your gut and make your intestinal wall leaky, allowing toxins to reach your liver and cause inflammation.
Scientific Claim
Ultra-processed foods are associated with gut microbiota dysbiosis and increased intestinal permeability ('leaky gut'), which may promote translocation of bacterial endotoxins like lipopolysaccharide to the liver, triggering inflammation and contributing to MASLD progression.
Original Statement
“UPFs may facilitate reductions in microbial diversity... Disruption of this balance... leads to increased intestinal permeability—a phenomenon termed 'leaky gut'... lipopolysaccharides (LPSs) from Gram-negative bacteria translocate into the bloodstream and activate Toll-like receptors (TLRs)... promoting inflammatory responses that drive the progression to MASH.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The pathway is plausible and supported by indirect evidence (animal models, small human microbiome studies), but no human study in the review demonstrates that UPFs directly cause leaky gut leading to MASLD. The language implies mechanistic certainty.
More Accurate Statement
“Higher consumption of ultra-processed foods is associated with alterations in gut microbiota composition and increased intestinal permeability, which are hypothesized to contribute to liver inflammation and metabolic dysfunction-associated steatotic liver disease via the gut-liver axis.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether reducing UPF intake restores gut barrier integrity and reduces endotoxemia in individuals with MASLD.
Whether reducing UPF intake restores gut barrier integrity and reduces endotoxemia in individuals with MASLD.
What This Would Prove
Whether reducing UPF intake restores gut barrier integrity and reduces endotoxemia in individuals with MASLD.
Ideal Study Design
A 16-week RCT of 80 adults with MASLD and elevated serum LPS, randomized to a UPF-free diet (≤5% of calories) vs. habitual diet, measuring fecal microbiota (16S rRNA), serum LPS, zonulin (gut permeability marker), and liver fat (MRI-PDFF) as primary endpoints.
Limitation: Microbiome changes may be secondary to weight loss or improved diet quality; hard to isolate UPF-specific effects.
Prospective Cohort StudyLevel 2bWhether baseline gut dysbiosis and permeability mediate the association between UPF intake and future MASLD.
Whether baseline gut dysbiosis and permeability mediate the association between UPF intake and future MASLD.
What This Would Prove
Whether baseline gut dysbiosis and permeability mediate the association between UPF intake and future MASLD.
Ideal Study Design
A 5-year prospective cohort of 2,000 adults with baseline UPF intake, fecal microbiome sequencing, serum LPS, zonulin, and annual liver imaging to assess mediation of UPF-MASLD link via gut barrier markers.
Limitation: Cannot prove causation; microbiome is highly variable and influenced by many factors.
Animal Model StudyLevel 4Whether UPF-specific additives (e.g., emulsifiers) directly induce gut barrier disruption and hepatic inflammation in the absence of obesity.
Whether UPF-specific additives (e.g., emulsifiers) directly induce gut barrier disruption and hepatic inflammation in the absence of obesity.
What This Would Prove
Whether UPF-specific additives (e.g., emulsifiers) directly induce gut barrier disruption and hepatic inflammation in the absence of obesity.
Ideal Study Design
A 12-week study in C57BL/6 mice fed isocaloric diets: one with UPF emulsifiers (carboxymethylcellulose, polysorbate-80), one with whole-food controls, measuring gut permeability (FITC-dextran), LPS translocation, hepatic TLR4 activation, and liver fat, in lean mice.
Limitation: Mouse gut physiology differs from humans; cannot replicate complex human dietary patterns.
Evidence from Studies
Supporting (1)
This study says eating lots of highly processed foods may hurt your gut and liver by letting bad bacterial parts leak into your bloodstream and cause inflammation, which can lead to fatty liver disease.